Impact of Gender on the Outcome of Liver Transplantation for Hepatocellular Carcinoma

NCT05643833 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3769

Last updated 2022-12-09

No results posted yet for this study

Summary

This is a large-scale study in China to provide evidence and insights in the role of gender in LT for HCC by analyzing the data of 3769 recipients with HCC registered in the China Liver Transplant Registry.

Conditions

  • Cancer of Liver

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • Zhejiang University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-05-30
Completion
2022-10-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05643833 on ClinicalTrials.gov